AURAYNA
Live / Applied — First extension granted (statement of use) (as of 06 Feb 2026)
What this means for you
Not registered yet, but its 17 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98908185
- Mark type
- Stylized text
- Filed
- 17 Dec 2024
- Published for opposition
- 08 Jul 2025
- Attorney of record
- Lisa L. Mueller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease
Owner
- PRIOVANT THERAPEUTICS, INC., NEW YORK, NY, US
- PRIOVANT THERAPEUTICS, INC., NEW YORK, NY, US
Prosecution history
- 06 Feb 2026 — SOU EXTENSION 1 GRANTED
- 06 Feb 2026 — SOU EXTENSION 1 FILED
- 06 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Jun 2025 — ASSIGNED TO EXAMINER
- 17 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Dec 2024 — NEW APPLICATION ENTERED